Humabiologics, Inc.
Humabiologics, Inc., headquartered in the United States, is a pioneering entity in the biopharmaceutical industry, specialising in the development and distribution of innovative human-derived biological products. Founded in 2015, the company has rapidly established itself as a leader in regenerative medicine, focusing on advanced cellular therapies and tissue engineering. With a commitment to quality and scientific excellence, Humabiologics offers unique products such as human amniotic membrane and umbilical cord tissue, which are utilised in various medical applications, including wound healing and orthopaedic procedures. The company’s dedication to research and development has led to significant advancements in the field, positioning it as a trusted partner for healthcare providers seeking cutting-edge solutions. Humabiologics continues to expand its operational reach, contributing to the evolving landscape of regenerative medicine.
DitchCarbon Score
How does Humabiologics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Humabiologics, Inc.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Humabiologics, Inc.'s reported carbon emissions
Humabiologics, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential to monitor the company's future initiatives and commitments to understand its role in sustainability and climate responsibility within the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Humabiologics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
